版权说明：本文档由用户提供并上传，收益归属内容提供方，若内容存在侵权，请进行举报或认领
文档简介
EndovascularTreatmentofRenalArteryStenosisEndovascularTreatmentofRenaClinicalIndications
(Procedures)ClinicalIndications
(ProcedurAnatomyAnatomyKidneyanatomyKidneyanatomyEndovascularTreatmentofRenalArteryStenosesAimofthetreatment 1)RenovascularHypertension 2)RenalInsufficiencyEndovascularTreatmentofRenaRenovascularHypertension5%ofallhypertensivepatientsDuetoatherosclerosisorFMDDiagnosedafterSurgicalfollow-uporPTRA.PTRAdoesnotcureEssentialHypertensionRenovascularHypertension5%ofRenalInsufficiencyNephrosclerosisafterRASorocclusionPTRAisindicatedtoreverseorpreventthedeclineofkidneyfunctions8cmlongkidneyisthelowerlimitafterwhichkidneyfunctionmightbecompromisedRenalInsufficiencyNephrosclerIndicationsforPTRAFailedmedicaltherapyReducingdrugtreatmentPressuregradient>10%Morethan50%stenosisAssymmetricallossofrenalmassIndicationsforPTRAFailedmedEndovascularTreatmentofRenalArteryStenoses1)Treatmentofartherioscleroticostiallesions(80%)
dilatation+stenting2)Treatmentofpostostiallesionsdilatation(stentingifnecessary)3)TreatmentFMD
dilatation(stentingifnecessary)EndovascularTreatmentofRenaPost-ostiallesionPost-ostiallesionFibro-MuscularDysplasiaFibro-MuscularDysplasiaFibro-MuscularDysplasiaFibro-MuscularDysplasiaRestenosisafterstenting
Recentstudieshaveindicatedratesarebetween10-20%(muchbetterthanthe30%withjustPTA).Restenosisafterstenting
ReceTreatmentOptionsMedicalTreatmentPTAwithStentingSurgeryDialysis:RenalFunctionnevergetbetterTreatmentOptionsMedicalTreatGoldstandardtreatmenttoday…MedicaltreatmentACEinhibitorsandanewclassofAngiotensinreceptorblockers
Goldstandardtreatmenttoday…EndovascularOptions:PTAorStenting?1999:PeterVandeVen,randomizedtrial
PTAvsStentinginostiallesionPTAStentingNumberofpatients4243Primarypatencyrate29%75%Primarysuccessrate57%88%Restenosispost-procedure48%14%EndovascularOptions:PTAorSLiterature…Literature…ProductStrategies014”Cardiologist,Radiologists,VascSurgeons.Balloon:M3RxStents:CorinthianIQonM3Wire,Stabilizer7-8FVistaBriteTiporIG
035’RadiologistwhoareusedtotraditionalPTAballoons,MorerangeinPTAballoonsBalloons:P3,OptaProStents:GenesispremountedonOPTA-PROWire035,Jindo,Storq8FVistabriteTiporIGProductStrategies014”035’Anewapproach:.018!AGOODCOMPROMISE!RadiologistwhoareusedtotraditionalPTAballoons,MorerangeinPTAballoonsBalloons:SlalomStent:GenesispremountedonOPTA-PROWire018,SV6-7FVistabriteTiporIGAnewapproach:.018!AGOODCAdvantagesof.014systemsLessspasmwith.014wireLesswirelengthSmallerpuncturesiteStentprotectedbyGCGoodsupportAdvantagesof.014systemsEndovascularTreatmentofRenalArteryStenoses
Throughthegroinusing8FmaterialsCanbedownsizedto7FusingM3EndovascularTreatmentofRena肾动脉支架植入术详解课件Emerald.035Emerald.035Emerald.035+PigtailTempo4-5F65cmEmerald.035+PigtailTempo4Emerald.035+RenalCurveTempo4F65cmEmerald.035+RenalCurveTemEmerald.035+RenalCurveTempo4F65cmEmerald.035+RenalCurveTemEmerald.035+RDCVistaBriteTip8F55cmEmerald.035+RDCVistaBriteEmerald.035+RDCVBT8F55cm+OptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+OptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+OptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+CorinthianIQonOptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+CorinthianIQonOptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+CorinthianIQonOptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+CorinthianIQonOptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+CorinthianIQEmerald.035+RDCVBT8F55cmEndovascularTreatmentofRenalArteryStenoses2)Throughthegroinusingthenew 6FmaterialsEndovascularTreatmentofRena肾动脉支架植入术详解课件.014Stabilizer.014Stabilizer.014Stabilizer+6FBriteTipSheath55cm.014Stabilizer+6FBriteTip.014Stabilizer+6FBTS55cm+RDCTempo4F.014Stabilizer+6FBTS55cm.014Stabilizer+6FBTS55cm+RDCTempo4F.014Stabilizer+6FBTS55cm.014Stabilizer+6FBTS55cm+RDCTempo4F.014Stabilizer+6FBTS55cm.014Stabilizer+6FBTS55cm+RDCTempo4F.014Stabilizer+6FBTS55cm.014Stabilizer+6FBTS55cm+M3.014Stabilizer+6FBTS55cm.014Stabilizer+6FBTS55cm+M3.014Stabilizer+6FBTS55cm.014Stabilizer+6FBTS55cm+CorinthianIQonM3.014Stabilizer+6FBTS55cm.014Stabilizer+6FBTS55cm+CorinthianIQ.014Stabilizer+6FBTS55cmEndovascularTreatmentofRenalArteryStenoses3)ThroughabrachialaccessEndovascularTreatmentofRenaTempo4FMP+.014StabilizerTempo4FMP+.014StabilizerBriteTipSheath6F90cm+.014StabilizerBriteTipSheath6F90cm+.01BriteTipSheath6F90cm+.014StabilizerBriteTipSheath6F90cm+.01BriteTipSheath6F90cm+RDCTempo4F+.014StabilizerBriteTipSheath6F90cm+RDCBTS6F90cm+.014StabilizerBTS6F90cm+.014StabilizerBTS6F90cm+.014Stabilizer+M3BTS6F90cm+.014Stabilizer+BTS6F90cm+.014Stabilizer+M3BTS6F90cm+.014Stabilizer+BTS6F90cm+.014Stabilizer+CorinthianIQonM3BTS6F90cm+.014Stabilizer+BTS6F90cm+.014Stabilizer+CorinthianIQonM3BTS6F90cm+.014Stabilizer+BTS6F90cm+.014Stabilizer+CorinthianIQonM3BTS6F90cm+.014Stabilizer+EndovascularTreatmentofRenalArteryStenosesProceduralPostprocedureEndovascularTreatmentofRenaEndovascularTreatmentofRenalArteryStenosesPreoperativePostoperativeEndovascularTreatmentofRenaEndovascularTreatmentofRenalArteryStenosisEndovascularTreatmentofRenaClinicalIndications
(Procedures)ClinicalIndications
(ProcedurAnatomyAnatomyKidneyanatomyKidneyanatomyEndovascularTreatmentofRenalArteryStenosesAimofthetreatment 1)RenovascularHypertension 2)RenalInsufficiencyEndovascularTreatmentofRenaRenovascularHypertension5%ofallhypertensivepatientsDuetoatherosclerosisorFMDDiagnosedafterSurgicalfollow-uporPTRA.PTRAdoesnotcureEssentialHypertensionRenovascularHypertension5%ofRenalInsufficiencyNephrosclerosisafterRASorocclusionPTRAisindicatedtoreverseorpreventthedeclineofkidneyfunctions8cmlongkidneyisthelowerlimitafterwhichkidneyfunctionmightbecompromisedRenalInsufficiencyNephrosclerIndicationsforPTRAFailedmedicaltherapyReducingdrugtreatmentPressuregradient>10%Morethan50%stenosisAssymmetricallossofrenalmassIndicationsforPTRAFailedmedEndovascularTreatmentofRenalArteryStenoses1)Treatmentofartherioscleroticostiallesions(80%)
dilatation+stenting2)Treatmentofpostostiallesionsdilatation(stentingifnecessary)3)TreatmentFMD
dilatation(stentingifnecessary)EndovascularTreatmentofRenaPost-ostiallesionPost-ostiallesionFibro-MuscularDysplasiaFibro-MuscularDysplasiaFibro-MuscularDysplasiaFibro-MuscularDysplasiaRestenosisafterstenting
Recentstudieshaveindicatedratesarebetween10-20%(muchbetterthanthe30%withjustPTA).Restenosisafterstenting
ReceTreatmentOptionsMedicalTreatmentPTAwithStentingSurgeryDialysis:RenalFunctionnevergetbetterTreatmentOptionsMedicalTreatGoldstandardtreatmenttoday…MedicaltreatmentACEinhibitorsandanewclassofAngiotensinreceptorblockers
Goldstandardtreatmenttoday…EndovascularOptions:PTAorStenting?1999:PeterVandeVen,randomizedtrial
PTAvsStentinginostiallesionPTAStentingNumberofpatients4243Primarypatencyrate29%75%Primarysuccessrate57%88%Restenosispost-procedure48%14%EndovascularOptions:PTAorSLiterature…Literature…ProductStrategies014”Cardiologist,Radiologists,VascSurgeons.Balloon:M3RxStents:CorinthianIQonM3Wire,Stabilizer7-8FVistaBriteTiporIG
035’RadiologistwhoareusedtotraditionalPTAballoons,MorerangeinPTAballoonsBalloons:P3,OptaProStents:GenesispremountedonOPTA-PROWire035,Jindo,Storq8FVistabriteTiporIGProductStrategies014”035’Anewapproach:.018!AGOODCOMPROMISE!RadiologistwhoareusedtotraditionalPTAballoons,MorerangeinPTAballoonsBalloons:SlalomStent:GenesispremountedonOPTA-PROWire018,SV6-7FVistabriteTiporIGAnewapproach:.018!AGOODCAdvantagesof.014systemsLessspasmwith.014wireLesswirelengthSmallerpuncturesiteStentprotectedbyGCGoodsupportAdvantagesof.014systemsEndovascularTreatmentofRenalArteryStenoses
Throughthegroinusing8FmaterialsCanbedownsizedto7FusingM3EndovascularTreatmentofRena肾动脉支架植入术详解课件Emerald.035Emerald.035Emerald.035+PigtailTempo4-5F65cmEmerald.035+PigtailTempo4Emerald.035+RenalCurveTempo4F65cmEmerald.035+RenalCurveTemEmerald.035+RenalCurveTempo4F65cmEmerald.035+RenalCurveTemEmerald.035+RDCVistaBriteTip8F55cmEmerald.035+RDCVistaBriteEmerald.035+RDCVBT8F55cm+OptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+OptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+OptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+CorinthianIQonOptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+CorinthianIQonOptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+CorinthianIQonOptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+CorinthianIQonOptaProEmerald.035+RDCVBT8F55cmEmerald.035+RDCVBT8F55cm+CorinthianIQEmerald.035+RDCVBT8F55cmEndovascularTreatmentofRenalArteryStenoses2)Throughthegroinusingthenew 6FmaterialsEndovascularTreatmentofRena肾动脉支架植入术详解课件.014Stabilizer.014Stabilizer.014Stabilizer+6FBriteTipSheath55cm.014Stabilizer+6FBriteTip.014Stabilizer+6FBTS55cm+RDCTempo4F.014Stabilizer+6FBTS55cm.014Stabilizer+6FBTS55cm+RDCTempo4F.014Stabilizer+6FBTS55cm.014Stabilizer+6FBTS55cm+RDCTempo4F.014Stabilizer+6FBTS55cm.014Stabilizer+6FBTS55cm+RDCTempo4F.014Stabilizer+6FBTS55cm.014Stabilizer+6FBTS55cm+M3.014Stabilizer+6FBTS55cm.014Stabilizer+6FBTS55cm+M3.014Stabilizer+6FBTS55cm.014
温馨提示
- 1. 本站所有资源如无特殊说明，都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等，如果需要附件，请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸，网页内容里面会有图纸预览，若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间，仅对用户上传内容的表现方式做保护处理，对用户上传分享的文档内容本身不做任何修改或编辑，并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容，请与我们联系，我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025年度拆除工程风险评估及应急预案
- 2025年度新能源项目场站建设与运营管理合同
- 2025年度电池储能系统设计与集成服务合同
- 2025年度商业秘密保护保密劳动合同及保密协议
- 2025年度城市道路临时停车位租赁及交通管理合同
- 2025年度彩钢板隔墙快速安装服务合同
- 2025年度体育赛事赞助商提成协议
- 2025年冷墩钢合作协议书
- 如何选择理财顾问计划
- 多元文化背景下的艺术教育计划
- 2025年业务员工作总结及工作计划模版（3篇）
- 必修3《政治与法治》 选择题专练50题 含解析-备战2025年高考政治考试易错题（新高考专用）
- 2024年连云港市赣榆区区属国企对外招聘笔试真题
- 海南省海口市2024-2025学年八年级上学期期末考试数学试题（含答案）
- 二零二五版电商企业兼职财务顾问雇用协议3篇
- 2025年注射用赖氮匹林项目可行性研究报告
- 课题申报参考：流视角下社区生活圈的适老化评价与空间优化研究-以沈阳市为例
- 2025江西吉安市新庐陵投资发展限公司招聘11人高频重点提升（共500题）附带答案详解
- 深圳2024-2025学年度四年级第一学期期末数学试题
- 2024-2025学年成都市高新区七年级上英语期末考试题（含答案）
- 17J008挡土墙(重力式、衡重式、悬臂式)图示图集
评论
0/150
提交评论